Related by context. All words. (Click for frequent words.) 67 S aureus 65 penicillin resistant Streptococcus 65 methicillin sensitive 65 vancomycin resistant Staphylococcus aureus 64 methicillin susceptible Staphylococcus aureus 64 Escherichia coli Klebsiella pneumoniae 64 Enterococcus faecium 63 Enterobacter cloacae 63 methicillin resistant S. aureus 63 carbapenem resistant 63 oxacillin 63 nasal carriage 62 methicillin resistant MRSA 62 Neisseria gonorrhoeae 62 methicillin susceptible 61 P aeruginosa 61 Epstein Barr Virus EBV 61 mediastinitis 61 vancomycin resistant 61 Staphylococcus aureus MSSA 61 methicillin resistant 61 Methicillin resistant S. aureus 61 antibiotic methicillin 61 enterococcal 61 Staphylococcus epidermidis 61 N. gonorrhoeae 61 bacterium Mycobacterium tuberculosis 61 S. aureus MSSA 60 Enterococcus faecalis 60 pneumoniae PRSP 60 Streptococcus pyogenes 60 Klebsiella pneumonia 60 Salmonella Campylobacter 60 Streptococcus pneumonia 60 necrotizing pneumonia 60 pneumoniae 60 Trypanosoma cruzi 60 Chlamydia trachomatis infection 60 FluCAM arm 60 Bacteremia 60 enteroviral 59 metastatic neuroendocrine tumors 59 discontinued Viread 59 IgG4 59 Haemophilus 59 HCV Hepatitis C 59 Typhimurium 59 bacterium Neisseria meningitidis 59 serogroup B 59 bacteraemia 59 SSc 59 ano genital warts 59 N. meningitidis 59 BRSV 59 Mycoplasma pneumoniae 59 vancomycin resistant enterococci 59 Trichomonas vaginalis 59 Salmonella typhi 59 coagulase negative staphylococci 59 Streptococcus agalactiae 59 K. pneumoniae 59 Ribavirin causes 59 resistant Staphylococcus aureus MRSA 59 Chlamydia pneumoniae 59 H. influenzae 58 Poliovirus 58 MRSA colonization 58 Lymphocytic 58 S.aureus 58 Vancomycin resistant 58 methicillin resistant staph aureus 58 HIV coinfected 58 Streptococcus pneumoniae Haemophilus influenzae 58 HIV1 58 V. vulnificus 58 vancomycin resistant enterococci VRE 58 Chlamydophila pneumoniae 58 Salmonella Shigella 58 fluconazole resistant 58 Bordetella pertussis 58 Chlamydia trachomatis 58 hypereosinophilic syndrome 58 USA# strain 58 drug resistant Streptococcus 58 associated diarrhea CDAD 58 Staphyloccus aureus 58 assay detects 58 lymphocytosis 58 N Engl J 58 cytologically confirmed 58 methicillin susceptible MSSA 58 Plasmodium ovale 58 Moraxella catarrhalis 58 Antibiotic resistant 57 Intravitreal injections 57 bronchoalveolar lavage 57 mupirocin 57 Burkholderia pseudomallei 57 ESBL producing 57 Mycobacterium bovis 57 Staphylococcus aureus S. aureus 57 dermatophytes 57 L. pneumophila 57 lymphadenopathy 57 cytomegalovirus infection 57 Staphylococcus aureus MRSA 57 essential thrombocythemia ET 57 virus HBV 57 IgM antibodies 57 linezolid resistant 57 Corynebacterium 57 immunocompetent 57 C. trachomatis 57 Balamuthia 57 HBeAg negative 57 abnormal hematopoietic cells 57 genital ulcers 57 neisseria 57 Arch Intern Med 57 vaginal candidiasis 57 Visceral leishmaniasis 57 BRAF V#E 57 nasopharyngeal specimens 57 anaphylactic reactions bronchospasm 57 faecium 57 brand ciclesonide HFA 57 diphtheria pertussis whooping cough 57 simian foamy virus 57 stage IIIb IV 57 sulfamethoxazole 57 simplex virus 57 asymptomatic carriers 57 nontuberculous mycobacteria 57 causative organism 57 vitreous floaters 57 colorectal adenocarcinoma 57 Methicillin 57 transthyretin TTR 57 staphylococci 56 seronegative 56 pT3 56 R5 tropic 56 causing hypomethylation 56 lung ovary 56 Opportunistic infections 56 Proteus mirabilis 56 Staphylococcus Aureus 56 J Am Coll 56 tryptase 56 Endometrial 56 bacterium Chlamydia trachomatis 56 seropositivity 56 GABHS 56 latent tuberculosis TB 56 hemorrhagic cystitis 56 Human papilloma virus 56 orf virus 56 Methicillin resistant 56 colorectal carcinoma 56 Asymptomatic 56 S. suis 56 Enterococcus faecalis vancomycin susceptible 56 CYT# potent vascular disrupting 56 renal cell carcinomas 56 Haemophilus influenzae 56 cytopathic 56 Candida species 56 fluorescent antibody 56 Neisseria meningitidis 56 histologic subtype 56 PCR assay 56 IgG antibody 56 Porphyromonas gingivalis 56 Trichophyton rubrum 56 underwent surgical resection 56 myelodysplastic myeloproliferative diseases 56 genital ulcer 56 bacteriuria 56 Chlamydia psittaci 56 Legionella pneumophila 56 Methicillin Resistant Staphylococcus aureus 56 Klebsiella pneumoniae 56 MRSA isolates 56 NMIBC 56 Salmonella enterica 56 -#.# log# copies mL 56 prostate cancer CaP 56 Xpert TM 56 Multidrug resistant 56 HepC 56 S. enterica 56 Hepatitis B HBV 56 pyogenes 56 S. aureus isolates 56 FUSILEV enhances 56 T. mentagrophytes 56 nasopharyngeal swabs 56 pregnancy bacterial vaginosis 56 lupus anticoagulant 56 P. ovale 56 M. leprae 56 susceptible isolates 56 #:#-# [029] 56 S. aureus MRSA 56 STEC O# 56 ELISPOT 56 vancomycin resistant Enterococcus faecium 56 cSSSIs 56 Respiratory syncytial virus RSV 56 completely resected 55 coinfections 55 hemagglutination inhibition HAI 55 Polymorphisms 55 metastatic malignant 55 S. pyogenes 55 gastric carcinoma 55 chronic eosinophilic leukemia 55 mucus saliva 55 atrophic gastritis 55 macrolide resistant 55 castration resistant hormone refractory 55 orthopoxvirus 55 bactericidal activity 55 Haemophilus influenza 55 dornase alfa 55 oropharyngeal candidiasis OPC 55 clade B 55 Staphylococcus aureus methicillin susceptible 55 mcg QD 55 HER2 expression 55 epidermidis 55 Enterobacter 55 Enterobacter sakazakii 55 Staphylococcus bacteria 55 Pasteurella multocida 55 BI/NAP#/# 55 Salmonella spp 55 urogenital infections 55 Antitumor 55 intra abdominal infections 55 Catheter Associated 55 novel VDA molecule 55 CCR5 delta# 55 uterine cervix 55 precursor lesions 55 epithelial tumors 55 meticillin resistant Staphylococcus aureus 55 quinolone resistant 55 #S rRNA gene 55 acute herpetic keratitis 55 humanized therapeutic 55 lactate dehydrogenase 55 T. pallidum 55 BRAF gene mutations 55 J. Clin 55 genus Plasmodium 55 S. typhi 55 Flavivirus 55 Human papillomavirus 55 nonbacterial 55 oseltamivir resistant 55 achieved CCyR 55 H pylori 55 #:#-# [031] 55 Candida infection 55 MDRSP 55 HBeAg 55 invasive carcinomas 55 MRSA Clostridium difficile 55 Bilive TM combined 55 Cathepsin B 55 ESBLs 55 enterotoxigenic E. coli 55 chlamydial infections 55 IPAH 55 glycopeptide 55 Upregulation 55 chlamydial 55 candidemia 55 Streptococci 55 Virus Infection 55 splenocytes 55 Vaccine Protects Against 55 Streptococcus pneumoniae pneumococcus 55 surgically resected 55 aphthous ulcers 55 intestinal metaplasia 55 Human papillomavirus HPV 55 HBsAg positive 55 hematological parameters 55 bacterium Streptococcus 54 leiomyomas 54 antiretroviral naïve 54 CIN2 + 54 serologic testing 54 Clostridium difficile infections 54 papillary renal cell carcinoma 54 secretions organs 54 Chlamydia gonorrhea 54 elevated ALT 54 lymphovascular invasion 54 diaper dermatitis complicated 54 fluoroquinolone resistant 54 E. coli STEC 54 vancomycin resistant Enterococcus 54 Autoantibodies 54 locoregional recurrence 54 advanced adenoma 54 nodal metastasis 54 cervicitis 54 herpes zoster shingles 54 P. falciparum malaria 54 Enterococci 54 Sezary syndrome 54 causative organisms 54 Fibroblast 54 NRTI resistance 54 e antigen HBeAg 54 proctitis 54 CHIKV 54 Basal Cell 54 coinfected 54 HBeAg negative patients 54 underwent resection 54 Cepheid Xpert 54 surface antigen HBsAg 54 prednisone prednisolone plus 54 Cytotoxic T 54 Entamoeba histolytica 54 infections cIAI 54 Cancer Res 54 Adenomas 54 Staphylococci 54 Candidiasis 54 Besivance TM 54 CYP#A# CYP#D# 54 peripheral blood mononuclear 54 Trichinella 54 #:#-# [023] 54 S. aureus bacteremia 54 replicon 54 b Hib 54 rickettsial 54 CD8 + lymphocytes 54 pseudomembranous colitis 54 Varicella zoster virus 54 bacterial biothreat agents 54 resistant hormone refractory 54 syngeneic 54 Haemophilus influenzae Moraxella catarrhalis 54 antibody titer 54 Serological 54 Plasmodium vivax 54 coinfection 54 Pneumocystis 54 C. difficile toxins 54 Latent TB 54 aeruginosa 54 agonistic human 54 IgA antibodies 54 bFGF 54 Alferon LDO 54 Vitrasert R 54 pneumococci 54 plasmodium falciparum 54 microorganisms Staphylococcus aureus 54 haematologic 54 biochemical relapse 54 C. jejuni 54 Clostridium difficile C. difficile 54 Allogeneic 54 acinetobacter 54 Enteroviruses 54 serum antibody 54 anthracycline induced 54 reaction RT PCR 54 Atypical Hemolytic Uremic Syndrome 54 hemodynamically significant 54 Stenotrophomonas maltophilia 54 HLA DRB1 * 54 leiomyoma 54 interleukin IL -# 54 extracapsular extension 54 substantially excreted 54 glutamic acid decarboxylase 54 Cryptococcus neoformans 54 conductance regulator 54 Escherichia coli O# 54 ASCUS 54 HLA DQ2 54 candida albicans 54 varicella zoster virus VZV 53 constitutively expressed 53 Staph Aureus 53 recurrent metastatic 53 Acinetobacter baumannii 53 neurological manifestations 53 S. aureus infections 53 Gram positive cocci 53 etiologic agent 53 chlamydia trachomatis 53 quadrivalent 53 Helicobacter pylori infection 53 Ph + acute lymphoblastic 53 Serologic 53 erythromycin resistant 53 E. faecium 53 binds selectively 53 CYP#C# [002] 53 intravesical infusion therapy 53 allogeneic HSCT 53 resistant Staphylococcus aureus 53 Babesia 53 Genital HPV 53 relapsed MM 53 Francisella tularensis 53 Nocardia 53 pretreatment serum 53 visit www.genenews.com 53 immunosuppressed patients 53 immunopathology 53 urothelial 53 Nosema apis 53 cisplatin resistant 53 hamartomas 53 streptococcal 53 BSIs 53 urethritis 53 white petrolatum Ointment 53 opportunistic pathogen 53 plasma pharmacokinetics 53 Staphylococcus 53 immunocompetent patients 53 intact parathyroid hormone 53 USP Tablets MOVIPREP ® 53 S. aureus strains 53 nodal metastases 53 human rhinovirus HRV 53 Staphylococcal 53 unresectable tumors 53 methicillin susceptible S. aureus 53 Pneumococcus 53 Aspergillus 53 IgA deficiency 53 Molluscum 53 lymphogranuloma venereum 53 CD# + [001] 53 herpes keratitis Hepatitis C 53 throat discharges saliva 53 mucinous 53 S. pneumoniae 53 Treponema pallidum 53 Anaplasma 53 basal cell carcinoma BCC 53 gastrointestinal stromal tumors GISTs 53 Extensively drug 53 amebiasis 53 Rimantadine 53 IN COMBINATION WITH 53 Staphylococcus aureus 53 circulating endothelial cells 53 poor metabolizers 53 Clostridia 53 alanine aminotransferase 53 gonococcal infections 53 intra abdominal abscess 53 K#N 53 superficial basal cell carcinoma 53 BCR ABL mutations 53 Histologic 53 genotypic resistance 53 airborne droplets 53 Panton Valentine leukocidin PVL 53 Methicillin Resistant 53 renal pelvis 53 nondiabetic patients 53 meningococcus 53 candidiasis 53 differentially regulated 53 urticaria hives 53 rotaviruses 53 p# biomarker 53 endometrial ovarian 53 Enterobacteriaceae 53 oral thrush 53 Systemic lupus erythematosus SLE 53 BRAF V#E mutation 53 S. aureus 53 ovarian carcinoma 53 kidney allograft 53 K ras mutations 53 malayi 53 aspartate aminotransferase 53 Parainfluenza 53 pneumonia tetanus 53 virus XMRV 53 Adenoviral 53 TIMP 53 Cystatin C 53 barbiturates benzodiazepines 53 Mycobacterium tuberculosis M.tb 53 leptospira 53 lamivudine resistant 53 human metapneumovirus 53 FLT3 mutations 53 Inactivation 53 immunoblotting 53 cytokeratin 53 J Shoulder Elbow 53 Staphylococcus aureus infections 53 serum aminotransferase levels 53 Cytomegalovirus CMV 53 recovery CRp 53 Ep CAM 53 coxsackie 53 HER2 HER2 53 includes S. anginosus 53 neoplasias 53 causative agents 53 opportunistic pathogens 53 Highly Pathogenic 53 Hepatitis C HCV 53 #:#-# [020] 53 HER2 positivity 53 obligate intracellular 53 Saccharomyces boulardii 53 subtyped 53 vaginal yeast infections 53 HLA DR2 53 DAS# CRP 53 Western blotting 53 antineoplastic effects 53 nonmetastatic 53 dysplastic lesions 52 apolipoprotein B 52 clinico pathological 52 Clin Chem 52 serogroup 52 aplastic anemia AA 52 TB MDR TB 52 castrate resistant 52 headache abdominal pain 52 penile cancers 52 Propionibacterium 52 Leptospira 52 pT2 52 murine leukemia virus 52 Pneumocystis pneumonia PCP 52 immunoglobulin G 52 Neisseria meningitides 52 Daptomycin 52 documented candidiasis 52 cefotaxime 52 Mycobacterium tuberculosis MTB 52 Panton Valentine Leukocidin 52 polyomavirus 52 hMPV 52 immunohistochemical staining 52 advanced neoplasia 52 gonococcal 52 Trypanosoma 52 MRSAid TM 52 LHRH receptor positive 52 S. intermedius 52 influenzae 52 gastric adenocarcinoma 52 mL/min/#.# m 2 52 Numoisyn ® Lozenges 52 serotype #A 52 Shows Promise Against 52 S. constellatus 52 breast carcinomas 52 haematological 52 ptau 52 thyroid carcinoma 52 sensitivity specificity 52 Campylobacter jejuni 52 obstructive coronary artery 52 #q# deletion 52 RT qPCR 52 PSA nadir 52 pseudomonas aeruginosa 52 Skin Structure Infections 52 polymicrobial 52 Mycobacterium leprae 52 Clade B 52 hepatocellular carcinomas 52 renal cortical 52 T. cruzi 52 CC genotype 52 Lymphatic filariasis 52 mutated K ras 52 advanced adenomas 52 hormone receptor status 52 vancomycin resistant enterococcus 52 hip osteonecrosis avascular 52 Resistant Staphylococcus Aureus 52 meningitides 52 Bullous 52 HCV antibodies 52 immunohistochemistry IHC 52 Adjuvant Treatment 52 HIV HCV coinfected 52 Immunohistochemical 52 Mycobacterium avium complex 52 TIMP 1 52 bovine thrombin 52 polymyxin B 52 IgA antibody 52 Hepatitis B virus HBV 52 T1c 52 H7 influenza 52 MRSA Methicillin 52 KRAS oncogene 52 genotypic 52 murine leukemia 52 naturally occurring histatin protein 52 pheochromocytoma 52 lead laced poultice 52 Respiratory Syncytial Virus RSV 52 abnormal cytology 52 tuberculosis hepatitis B 52 CCyR 52 gonorrhoeae 52 J Foot Ankle 52 prostate carcinoma 52 fluoroquinolone resistance 52 CD# CD# 52 tetracycline antibiotic 52 achieve sustained virologic 52 SGPT 52 immunohistochemical analysis 52 Squamous 52 nosocomial hospital 52 hypermethylated 52 Stage IIB 52 Test Detects 52 infliximab monotherapy 52 baseline serum creatinine 52 bloodborne 52 Mouse Model 52 nosocomial 52 NS#/#A protease 52 ovarian endometrial 52 Clostridium perfringens 52 undetectable HBV DNA 52 Renal Cell Carcinoma RCC 52 causative mutations 52 M#V 52 monogenic 52 breast carcinoma 52 Proc Am Soc 52 E. faecalis 52 TMPRSS2 ERG 52 nasal ointment 52 multidrug resistant strains 52 bacterial colonization 52 anogenital warts 52 osteosarcomas 52 baseline LDH 52 sero positive 52 bronchoalveolar lavage fluid 52 dual tropic 52 invasive lobular 52 papilloma virus 52 Nosocomial 52 extracapsular 52 monoinfected 52 fungal keratitis 52 HCl PEPCID ® famotidine 52 tigecycline 52 tissue transglutaminase 52 Flu Cy 52 immunostaining 52 echocardiographic parameters 52 Cytogenetic 52 Endocarditis 52 doi #.#/fj.#-# 52 infection sinusitis 52 virulence genes 52 neonatal meningitis 52 mRNA expression 52 Leukemias 52 Fasting blood glucose 52 Potassium Chloride Sodium Ascorbate 52 molecular diagnostic assay 52 Staph aureus 52 post transplant lymphoproliferative 52 whose tumors overexpress 52 steroidogenic 52 MIC# [001] 52 proton MR spectroscopy 52 orthologs 51 typhi 51 hepatoma 51 periodontal bacteria 51 Pulse CO Oximetry Pulse 51 allogeneic epidermal 51 KRAS mutations occur 51 Herpes simplex virus 51 C#Y 51 whipworm 51 miconazole nitrate 51 unknown etiology 51 blood coagulation disorders 51 meropenem 51 Propionibacterium acnes 51 potassium binder 51 coronary stenosis 51 type plasminogen activator 51 basal cell carcinoma squamous 51 staphylococcal 51 VRSA 51 PROSTVAC VF 51 Genital Warts 51 artificial arteriovenous dialysis 51 bioavailable testosterone 51 neomycin 51 clinicopathologic 51 pathologic diagnosis 51 transiently transfected 51 Serum concentrations 51 lichen planus 51 Moxifloxacin 51 monocytogenes 51 colorectal gastric 51 H. Pylori 51 Genotypes 51 Borrelia 51 ABCB1 51 Pelvic Inflammatory Disease 51 IDI MRSA 51 mononuclear cells 51 J Cataract Refract 51 CR nPR 51 sitosterol 51 dengue hemorrhagic fever DHF 51 Score TOS 51 Shiga toxin producing 51 hematopoietic cancers 51 Bacterial Vaginosis 51 SPREAD OF 51 Subtype 51 vaginal lesions 51 promoter methylation 51 deCODE ProstateCancer TM 51 tests miRview TM 51 BARACLUDE ® 51 metastatic pancreatic 51 immunoreactivity 51 CSF Tf 51 hypervirulent strain 51 Hepatitis B Virus 51 lung carcinomas 51 Treponema 51 Tyrosine Kinase Inhibitor 51 multiresistant 51 papular 51 LES EXPLOSIFS NORDEX LTEE 51 secretory proteins 51 anemia leukopenia 51 Immunohistochemical staining 51 chronic urticaria 51 Papillary 51 Lactobacillus casei 51 MKC# MT 51 G CSFs 51 coagulase 51 NNRTI resistance 51 Mutation Detection 51 Chemokine Receptor 51 ALT normalization 51 Aspergillus nidulans 51 CASES OF 51 antibiotics metronidazole 51 idiopathic PAH 51 jejuni 51 sunitinib Sutent ® 51 methicillin resistant staphylococcus 51 achieved sustained virological 51 heFH 51 prostate adenocarcinoma 51 HUMIRA resembles 51 pharmacodynamic biomarkers 51 MRSA Methicillin resistant Staphylococcus 51 Escherichia Coli 51 endometrial breast 51 Drug resistant strains 51 Transcriptome 51 antiseptic chlorhexidine 51 indinavir Crixivan 51 Mycobacterium tuberculosis TB 51 Relapsed Refractory 51 fatigue diarrhea nausea 51 Immunoassays 51 pancreatic prostate 51 MGd 51 Salmonella enterica serovar 51 enterobacteriaceae 51 immunomodulatory properties 51 CASES IN 51 rs# [004] 51 Herpes zoster 51 dermatophyte 51 cytomegalovirus CMV 51 5 HT2A serotonin 51 serologically 51 deCODE BreastCancer 51 anginosus group 51 B. longum 51 BALB c mice 51 cause cardiac channelopathies 51 HSV2 51 quinolone 51 lung esophageal 51 HBV genotype 51 coxsackievirus 51 Candida albicans 51 SNP rs# [002] 51 culture supernatants 51 Immunohistochemistry 51 semiquantitative 51 bone marrow reticulin deposition 51 heparanase 51 metastatic renal cell 51 Vancomycin Resistant 51 faecalis 51 thymidine kinase 51 Bartonella 51 HER2 ErbB2 51 staphylococcus aureus bacteria 51 Vidaza ® 51 vaginalis 51 probiotic Lactobacillus 51 vivax 51 radical prostatectomy RP 51 Enteritidis 51 multidrug resistant MDR 51 Onychomycosis 51 germline mutations 51 duchesse satin dress 51 histological subtype 51 Linezolid 51 LV dysfunction 51 Tinea pedis 51 bladder ovarian 51 oesophageal adenocarcinoma 51 postintervention 51 Alkaline Phosphatase 51 CA MRSA infections 51 baseline FEV 51 quantitative RT PCR 51 diaper dermatitis 51 perianal 51 MALT lymphoma 51 log# copies mL 50 ductal carcinomas 50 streptococcus pneumoniae 50 Hurthle cell 50 Epstein Barr virus EBV 50 Immunotherapeutic 50 cervical vaginal 50 deCODE AF TM 50 antiangiogenic activity 50 HepG2 cells 50 benzoic acid hyoscyamine sulfate 50 paramyxoviruses 50 Patients Receiving 50 fine needle aspirate 50 Helicos proprietary 50 helicobacter pylori 50 5 Fluorouracil 50 ceftazidime 50 antimicrobial susceptibility testing 50 Lymphoid 50 reverse transcription polymerase 50 ultrastructural 50 colon carcinoma 50 dacarbazine DTIC 50 bullous 50 untreated metastatic melanoma 50 baumannii 50 vulvovaginal candidiasis 50 RRM1 50 SIPC CRD # 50 DAS# remission 50 hypertrichosis occurred 50 Toxoplasma gondii 50 glucuronide 50 transluminal coronary angioplasty PTCA 50 TM PCA3 50 recombinant PSMA vaccine 50 Includes KCI proprietary 50 metaplasia 50 histopathological 50 Klebsiella 50 p# antigen 50 hormone receptor negative 50 PCA3 gene 50 ERBB2 50 VKORC1 50 distant metastasis 50 haemophilus influenzae type 50 urine cytology 50 PCR RFLP 50 CFTR cystic fibrosis transmembrane 50 Epithelial Cell 50 coagulase negative 50 bacterial vaginosis BV 50 Clindamycin 50 albicans 50 D Dimer 50 B. cepacia 50 Cutaneous 50 TO TREAT 50 PTPN# 50 Diptheria 50 cyclooxygenase COX 50 Cancer Epidemiol Biomarkers Prev 50 Prognostic significance 50 lymphocytic 50 bacteria Pseudomonas aeruginosa 50 FLT3 ITD 50 Oral Solution OSMOPREP 50 specific alkaline phosphatase 50 Ag Cu Pb 50 viral isolates 50 Vaginal Gel 50 methicillin 50 HER1 50 MRSA methicillin resistant 50 colonoscopy sigmoidoscopy 50 immunohistochemical 50 ug ml 50 bronchoalveolar lavage BAL 50 combination antiretroviral therapy 50 visceral metastases 50 Supplementary Table 50 dysentery hepatitis 50 Genotypic 50 variant allele 50 vibrio cholera 50 reaction PCR 50 Herpes Simplex Virus 50 vitro pharmacology 50 progesterone receptor PR 50 orchitis 50 refractory chronic lymphocytic 50 Factor Receptor 50 pathogenic bacterium 50 Shows Promising 50 Nasopharyngeal 50 Crimean Congo hemorrhagic fever 50 Papillomavirus 50 TTR gene 50 avian H#N# influenza 50 Situ Hybridization 50 pCR 50 inhalation ingestion 50 SIMPONI TM 50 herpesviruses 50 mIU ml 50 Borrelia burgdorferi 50 sulfonamide 50 Measles mumps 50 adeno 50 Combination REOLYSIN R 50 hyaluronidase enzyme 50 Dengue virus 50 naïve HCV 50 clinicopathological features 50 Tetanus Toxoids 50 severe congenital neutropenia 50 squamous 50 SensoLyte ™ 50 Ehrlichia 50 nonmelanoma 50 liposomal amphotericin B 50 SELDI TOF MS 50 trastuzumab Herceptin R 50 inactivating mutations 50 pancreatic adenocarcinoma 50 lysine residues 50 rFSH 50 pneumocystis 50 Conjugate Vaccine 50 demonstrated antitumor activity 50 CpG DNA 50 Selzentry TM 50 Antigens 50 HLA DR4 immune 50 HCV Genotype 50 poly ADP ribose polymerase 50 Citrobacter 50 maternal serum 50 BAXTER INTERNATIONAL 50 pretransplant 50 Ebola Marburg 50 missense mutations